Trials / Recruiting
RecruitingNCT04168099
Oral Gemifloxacin Versus Intravenous Cefotaxime in Treatment of Spontaneous Bacterial Peritonitis
Comparative Study Between the Efficacy of Oral Gemifloxacin and Intravenous Cefotaxime in Treatment of Spontaneous Bacterial Peritonitis
- Status
- Recruiting
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 60 (estimated)
- Sponsor
- Tanta University · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
oral Gemifloxacin versus intravenous Cefotaxime in treatment of spontaneous bacterial peritonitis
Detailed description
Comparative Study between the Efficacy of oral Gemifloxacin and intravenous Cefotaxime in treatment of spontaneous bacterial peritonitis
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Cefotaxime | Cefotaxime IV |
| DRUG | Gemifloxacin | Gemifloxacin oral |
Timeline
- Start date
- 2018-12-01
- Primary completion
- 2028-12-01
- Completion
- 2028-12-30
- First posted
- 2019-11-19
- Last updated
- 2019-11-19
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT04168099. Inclusion in this directory is not an endorsement.